Neuropsychopharmacology
- Pons connectivity correlates with neurophysiological and clinical signatures of predictive coding in psychosis2 years ago
- Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression2 years ago
- Neuroimaging for precision medicine in psychiatry2 years ago
- Environmental and neurodevelopmental contributors to youth mental illness2 years ago
- Neuroimaging education in psychiatric training2 years ago
- Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics2 years ago
- Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity2 years ago
Journal of Psychopharmacology
- A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium” by Vázquez et al. (Journal of Psychopharmacology, 2021, Vol. 35(8) 890–900)4 years ago
- Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway4 years ago
- Acute treatment with 5-hydroxytryptophan increases social approach behaviour but does not activate serotonergic neurons in the dorsal raphe nucleus in juvenile male BALB/c mice: A model of human disorders with deficits of sociability4 years ago
- Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences4 years ago
- A theory of the anxiolytic action of flumazenil in anxiety disorders4 years ago
- The cortical silent period in schizophrenia: A systematic review and meta-analysis focusing on disease stage and antipsychotic medication4 years ago
- Catechol-O-methyltransferase activity does not influence emotional processing in men4 years ago
European Neuropsychopharmacology
- The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders4 years ago
- Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”4 years ago
- New antidepressants: New day or false dawn?4 years ago
- Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism4 years ago
- Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment4 years ago
- Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder4 years ago
- Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?4 years ago